Dermatological Patent Spat Ends In Settlement

Law360, New York (November 17, 2009, 1:09 PM EST) -- Glenmark Pharmaceuticals Ltd. and Medicis Pharmaceutical Corp. have agreed to settle patent litigation over a steroid skin cream and a topical skin gel, and to co-develop a product for the treatment of acne.

Mumbai, India-based Glenmark announced Monday that it had settled all patent litigation relating to fluocinonide, the generic version of Medicis' Vanos cream, and ciclopirox olamine, the generic version of Medicis’ Loprox gel.

Under the terms of the license and settlement agreements, Glenmark will be able to launch a generic version of Vanos by...
To view the full article, register now.